Konstantinides, Stavros; Mavromanoli, Anna; Hobohm, Lukas
Diagnostics and Treatment of Pulmonary Embolism (2021)HERZ. Bd. 47. H. 2. 2022 S. 175-175
Wenger, Nicolas; Sebastian, Tim; Beer, Jurg H. et al.
Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER)THROMBOSIS RESEARCH. Bd. 220. 2022 S. 65-71
Nagy, Magdolna; Schellens, Joep; Hulshof, Anne-Marije et al.
Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control StudyBLOOD. Bd. 140. 2022 S. 8445-8446
Jurk, Kerstin; Rothenaicher, Korbinian F.; Gross, Kathrin et al.
Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot StudyFRONTIERS IN CARDIOVASCULAR MEDICINE. Bd. 9. 2022
Kremers, B. M. M.; Posma, J. N.; Heitmeier, S. et al.
Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery diseaseSCIENTIFIC REPORTS. Bd. 12. H. 1. 2022
Masoodi, Mojgan; Peschka, Manuela; Schmiedel, Stefan et al.
Disturbed lipid and amino acid metabolisms in COVID-19 patientsJOURNAL OF MOLECULAR MEDICINE-JMM. Bd. 100. H. 4. 2022 S. 555-568
Wiedenroth, Christoph B.; Bandorski, Dirk; Ariobi, Kanischka et al.
Does Age Matter? Pulmonary Endarterectomy in the Elderly Patient with CTEPHTHORACIC AND CARDIOVASCULAR SURGEON. Bd. 70. H. 08. 2022 S. 663-670
Sanchez, Olivier; Konstantinides, ?
Does Fibrinolytic Strategy of Pulmonary Embolism International ThrOmbolysis PEITHO-3 Trial Need More Strong EvidenceTHROMBOSIS AND HAEMOSTASIS. Bd. 122. H. 12. 2022 S. 2052-2053
Willems, Loes H.; Thijssen, Dick H. J.; Groh, Laszlo A. et al.
Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trialFRONTIERS IN CARDIOVASCULAR MEDICINE. Bd. 9. 2022
Creeper, Katherine J.; Cohen, Alexander T.; Alikhan, Raza et al.
Early Time Courses of Recurrent Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with CancerBLOOD. Bd. 140. 2022 S. 8515-8517